perioperative management of glp-1 agonists 2024 asa guidance receptor Agonists: Balancing Aspiration Risk with Therapeutic Benefit Perioperative management of patients taking

& Liu, B

human evidence is still emerging.) Musculoskeletal injury or post-surgical recovery Chronic tendonitis, ligament sprains, or joint pain Athletes or active individuals with overuse injuries Patients with GI inflammation or ulcerative symptoms Individuals seeking regenerative or anti-inflammatory support Generally well-tolerated in available data, but may include: Mild redness or irritation at injection site Transient headache, nausea, or dizziness (rare) Potential for allergic reaction (rare) Not FDA-approved

Together, they create a continuous cycle of NO production and protection , maintaining higher levels of bioavailable NO for longer periods

0 mg/dl) in women